STOCK TITAN

Journey Medical Corporation (DERM) Stock News, Oct 2023-Mar 2024

DERM NASDAQ

Journey Medical Corporation develops, sells and markets FDA-approved prescription pharmaceutical products for dermatological conditions. The company is a commercial-stage dermatology pharmaceutical issuer with a portfolio of branded prescription drugs marketed in the United States.

Recurring news for DERM centers on quarterly and annual financial results, corporate updates, and commercialization progress across its dermatology portfolio. Company updates frequently discuss Emrosi™, a modified-release minocycline product approved for inflammatory lesions of rosacea in adults, including payer access, group purchasing organization contracts, prescription demand, product revenue, and clinical data presentations or publications for Emrosi/DFD-29.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.61%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.00%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
conferences
-
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.10%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.62%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.94%
Tags

FAQ

What is the current stock price of Journey Medical (DERM)?

Journey Medical (DERM) last closed at $3.90.

What is the market cap of Journey Medical (DERM)?

The market cap of Journey Medical (DERM) is approximately $110.1M.